Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
Total Debt/Equity

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Total Debt/Equity History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Total Debt/Equity(x) 0.020.030.04--

What is the latest Total Debt/Equity ratio of GLAND PHARMA ?

The latest Total Debt/Equity ratio of GLAND PHARMA is 0.02 based on Mar2026 Consolidated results.
Year Total Debt/Equity
Mar20260.02
Mar20250.03
Mar20240.04
Mar2023-
Mar2022-

How is Total Debt/Equity of GLAND PHARMA Trending?

Years Total Debt/Equity % Change
Mar2026 0.02
-33.33
Mar2025 0.03
-25.00
Mar2024 0.04
0
Mar2023 0
0
Mar2022 0 -

Other Financial Ratios of GLAND PHARMA


Compare Total Debt/Equity ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹42,907.4 Cr 0.9% 5.3% 26.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -0.1% 0.5% 14% Stock Analytics
DIVIS LABORATORIES ₹218,972.0 Cr -0.9% 21.1% 25.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,358.0 Cr -1.3% 1.1% 32.7% Stock Analytics
CIPLA ₹118,916.0 Cr 0.2% 2.1% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,824.0 Cr 0.2% -7.7% -7.5% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

0.9%

5.3%

26.7%

SENSEX

0.5%

2.6%

-3.7%


You may also like the below Video Courses